Active Surveillance Prostate Cancer Video Chat, September 24th, 2025
Dr. JONATHAN EPSTEIN IS BACK for an AnCan webinar on Tuesday, September 30th at 8 pm Eastern! “Interpreting Prostate Needle Biopsies in Today’s World” Bx explained from early AS to advanced prostate cancer, including AI – with lots of time for Q&A. Register at https://ow.ly/PpoX50WVsJ4
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
NEW monthly GAY & BISEXUAL MEN’S Prostate Cancer Group starting Tuesday, October 14th. Sign up at https://ancan.org/contact-us/
Chat Log:
Eric- Atlanta
Tonight is recorded. Feel free to turn off the camera or change your name.
Eric- Atlanta
2nd Opinions for MRIs Botimage AI for MRIs: https://botimageai.com/prostatid/ ~$250, can also be used for biopsy targeting guidance -Second opinion of MRI from Johns Hopkins Images and Reports for Providers | Johns Hopkins Radiology (hopkinsmedicine.org) Email: eradiologycenter@jhmi.edu Phone: 443-287-7378 Fax: 443-769-1210 NIH 2nd Opinion MRI (no fees): Choyke, Peter (NIH/NCI) Radiologist pchoyke@mail.nih.gov -Accolade Radiology NY, PA https://accoladeradiology.com/mritap…. Radiology Check (Switzerland) https://radiologycheck.com/en
I am interested in Dr. Wayne Brisbane’s issues because I’m setting up a consultation with him.
Lindsey Jang, West Los Angeles
Ok, thanks. Sorry to bother you.
Eric- Atlanta
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact:jonathaniraepstein@gmail.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -Johns Hopkins Pathology https://pathology.jhu.edu/patient-car…
AnCan Bill
Interpreting Prostate Needle Biopsies in Today’s World Dr. Jonathan Epstein, MD, Advanced Uropathology Featuring: Host: Dr. John Antonucci, MD Guest Panelist: Dr. Randall Jones PhD, REGISTER HERE: https://ow.ly/PpoX50WVsJ4
Thank you AS group, for the valuable input for Kevin
Wayne Zimmermann
wwzimmer@gmail.com for Wayne Zimmermann
Eric- Atlanta
Interpreting Prostate Needle Biopsies in Today’s World -8pm ET September 30th via AnCan Zoom.Please REGISTER HERE: https://ow.ly/PpoX50WVsJ4
Eric- Atlanta
To SAVE all the links in this chat, click on the 3 vertical dots at the top of this chat, and you can download the entire chat right now to your computer/phone.
Lindsey Jang, West Los Angeles
Thank you all so very much! I’m registered for next Tuesday’s webinar with Dr. Epstein.
Interpreting Prostate Needle Biopsies in Today’s World
Interpreting Prostate Needle Biopsies in Today’s World
Dr. Jonathan Epstein, MD, Advanced Uropathology
Reliable biopsies are critical to selecting the right treatment at all stages of prostate cancer – we’re talking needle tissue, not blood, btw. Get it wrong and you may get too much or too little treatment.
Reading pathology is part art and part science! AnCan Advisory Board Member, Dr. Jonathan Epstein is globally acknowledged to have the best eye in the genitourinary pathology world. AnCan frequently refers men to him for a 2nd opinion. His presentation will include:
Getting the most out of a 2nd Opinion
The relevance of cribriform, intraductal, ductal, & small cells
In our prostate cancer world, getting 2nd opinions is critical. It’s easy to find a medical second opinion, and you can have your pathology reread by the best. But MRIs – that’s been challenging.
Founder and Developer, Randall Jones, PhD, explains the technology and its uses. Hosted by AnCan Advisory Board Member and prostate cancer peer, Cdr. Mike Crosby
AnCan participants receive a $20 discount on their first submission – please be sure to mention us.
AnCan thanks the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine. Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators, and Participants.
AnCan does not accept sponsored promotions. Any drugs, protocols, or devices discussed are based solely on anecdotal peer experience or clinical evidence. AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so, call 1-800-332-1066 or download the interactive FDA Form 3500 https://www.fda.gov/media/76299/download
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.
Active Surveillance Prostate Cancer Video Chat, September 10th, 2025
UPCOMING PRESENTATION MRI 2nd Opinions….. ProstateID solves the challenge; getting 2nd opinions is critical. It’s easy to find a medical 2nd opinion, and you can get your pathology reread by the best! But MRIs – that’s been challenging. Now there’s an affordable AI-validated option that’s proven very reliable* – ProstateID. Join us on Wednesday, September 17th at 6:30 pm Eastern in the AnCan Barniskis Room https://www.gotomeet.me/AnswerCancer. Founder and Developer Randall Jones, PhD, explains the technology and its uses. Hosted by an AnCan Advisory Board Member and prostate cancer peer, Cdr. Mike Crosby *Sensitivity and Specificity in the mid-90% range … and hold Monday, September 29th, 8 pm Eastern for Dr. Jonathan Epstein. Title TBD and webinar link to follow.
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us. You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Eric- Atlanta
2nd Opinions for Biopsies: -Jonathan Epstein, MD, Contact: Contact:jonathaniraepstein@gmail.com https://advanceduropathology.com -Ming Zhou, MD, PHD, Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
Eric- Atlanta
PROMISE/COLOR Genetic Study (Free) w/ANCAN affiliate link: https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar
In our prostate cancer world, getting 2nd opinions is critical. It’s easy to find a medical 2nd opinion, and you can get your pathology reread by the best! But MRIs – that’s been challenging. Now there’s an affordable AI-validated option that’s proven very reliable* –ProstateID
*Sensitiviy and Specificity in the mid-90% range
Founder and Developer, Randall Jones, PhD explains the technology and its uses. Hosted by AnCan Advisory Board Member and prostate cancer peer, Dr. Mike Crosby.
No need to register ahead. Drop in and join us for this webinar.
